These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21738320)

  • 21. Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations.
    El Rhabori S; El Aissouq A; Daoui O; Elkhattabi S; Chtita S; Khalil F
    Heliyon; 2024 Feb; 10(3):e24551. PubMed ID: 38318045
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Samreen ; Qais FA; Ahmad I
    J Biomol Struct Dyn; 2023 Apr; 41(6):2189-2201. PubMed ID: 35067192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
    Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
    Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies.
    El-Wakil MH; El-Dershaby HA; Ghazallah RA; El-Yazbi AF; Abd El-Razik HA; Soliman FSG
    Bioorg Chem; 2024 Apr; 145():107226. PubMed ID: 38377818
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Divyashri G; Krishna Murthy TP; Sundareshan S; Kamath P; Murahari M; Saraswathy GR; Sadanandan B
    Bioimpacts; 2021; 11(2):119-127. PubMed ID: 33842282
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules.
    Vanajothi R; Vedagiri H; Al-Ansari MM; Al-Humaid LA; Kumpati P
    J Biomol Struct Dyn; 2022 May; 40(8):3385-3399. PubMed ID: 33200682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations.
    Belal A; Elkady H; Al-Karmalawy AA; Amin AH; Ghoneim MM; El-Sherbiny M; Al-Serwi RH; Abdou MA; Ibrahim MH; Mehany ABM
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies.
    Rampogu S; Parate S; Parameswaran S; Park C; Baek A; Son M; Park Y; Park SJ; Lee KW
    Comput Biol Chem; 2019 Dec; 83():107113. PubMed ID: 31493740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
    J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based virtual screening and molecular docking approaches to identify potential inhibitors against KIF2C to combat glioma.
    Hussein D; Saka M; Baeesa S; Bangash M; Alghamdi F; Al Zughaibi T; AlAjmi MF; Haque S; Rehman MT
    J Biomol Struct Dyn; 2024; 42(24):13816-13829. PubMed ID: 37942622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer.
    Ganji M; Bakhshi S; Shoari A; Ahangari Cohan R
    J Transl Med; 2023 Feb; 21(1):111. PubMed ID: 36765337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating physiochemical properties of FDA-approved orally administered drugs.
    Reese TC; Devineni A; Smith T; Lalami I; Ahn JM; Raj GV
    Expert Opin Drug Discov; 2024 Feb; 19(2):225-238. PubMed ID: 37921049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
    Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
    Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic antibacterial activity of Phyllanthus emblica fruits and its phytocompounds with ampicillin: a computational and experimental study.
    Saini R; Kumar V; Patel CN; Sourirajan A; Dev K
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):857-871. PubMed ID: 37522914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
    Jiang Y; Gao H
    Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the inhibitory potential of bioactive compounds against SARS-CoV-2 by in silico approach.
    Rani JMS; Akkarshana P; Neelaveni V; Mohan S; Rekha PD; Rao RM; Muthulakshmi L
    J Mol Model; 2024 Feb; 30(3):60. PubMed ID: 38321299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of high affinity ligands for β2-adrenergic receptor through pharmacophore-based high-throughput virtual screening and docking.
    Yakar R; Akten ED
    J Mol Graph Model; 2014 Sep; 53():148-160. PubMed ID: 25137647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of phytocompounds as potent inhibitors of sodium/glucose cotransporter-2 leading to diabetes treatment.
    Swargiary A; Daimari M; Swargiary A; Biswas A; Brahma D; Singha H
    J Biomol Struct Dyn; 2024 Feb; ():1-14. PubMed ID: 38379332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing of clinically proven bioactive compounds for targeted treatment of Alzheimer's disease using molecular docking approach.
    Vasanth Kanth TLB; Raha A; Vijay Murali RM; Yuvatha N; Kumaran K; Kirubakaran R; ArulJothi KN
    In Silico Pharmacol; 2023; 11(1):33. PubMed ID: 37920821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel hybrid virtual screening protocol based on pharmacophore and molecular docking for discovery of GSK-3β inhibitors.
    Liu X; Yu J; Luo Y; Dong H
    Chem Biol Drug Des; 2023 Feb; 101(2):326-339. PubMed ID: 35762873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.